Raia Drogasil Zukünftiges Wachstum
Future Kriterienprüfungen 5/6
Raia Drogasil wird ein jährliches Gewinn- und Umsatzwachstum von 24.8% bzw. 12% prognostiziert. Der Gewinn pro Aktie wird voraussichtlich wachsen um 24.2% pro Jahr. Die Eigenkapitalrendite wird in 3 Jahren voraussichtlich 21.9% betragen.
Wichtige Informationen
24.8%
Wachstumsrate der Gewinne
24.2%
EPS-Wachstumsrate
| Consumer Retailing Gewinnwachstum | 30.0% |
| Wachstumsrate der Einnahmen | 12.0% |
| Zukünftige Eigenkapitalrendite | 21.9% |
| Analystenabdeckung | Good |
| Zuletzt aktualisiert | 18 Nov 2024 |
Jüngste Aktualisierungen zum künftigen Wachstum
Earnings Beat: Raia Drogasil S.A. Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Models
Nov 08
Raia Drogasil S.A. Just Missed Earnings - But Analysts Have Updated Their Models
Aug 10The Raia Drogasil S.A. (BVMF:RADL3) Yearly Results Are Out And Analysts Have Published New Forecasts
Mar 10Recent updates
Earnings Beat: Raia Drogasil S.A. Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Models
Nov 08Raia Drogasil (BVMF:RADL3) Has A Pretty Healthy Balance Sheet
Oct 13Returns Are Gaining Momentum At Raia Drogasil (BVMF:RADL3)
Sep 25Raia Drogasil S.A. Just Missed Earnings - But Analysts Have Updated Their Models
Aug 10With Raia Drogasil S.A. (BVMF:RADL3) It Looks Like You'll Get What You Pay For
Jul 13Raia Drogasil (BVMF:RADL3) Seems To Use Debt Quite Sensibly
Apr 08Does Raia Drogasil (BVMF:RADL3) Deserve A Spot On Your Watchlist?
Mar 24Investors Met With Slowing Returns on Capital At Raia Drogasil (BVMF:RADL3)
Jan 29Raia Drogasil S.A.'s (BVMF:RADL3) Earnings Haven't Escaped The Attention Of Investors
Dec 29Does Raia Drogasil (BVMF:RADL3) Have A Healthy Balance Sheet?
Dec 12Do Raia Drogasil's (BVMF:RADL3) Earnings Warrant Your Attention?
Nov 27Returns On Capital At Raia Drogasil (BVMF:RADL3) Have Stalled
Oct 27Does Raia Drogasil (BVMF:RADL3) Have A Healthy Balance Sheet?
Sep 07Should You Be Adding Raia Drogasil (BVMF:RADL3) To Your Watchlist Today?
Aug 19Here's What To Make Of Raia Drogasil's (BVMF:RADL3) Decelerating Rates Of Return
Jul 18Is Raia Drogasil (BVMF:RADL3) Using Too Much Debt?
Jun 03Do Raia Drogasil's (BVMF:RADL3) Earnings Warrant Your Attention?
May 13Returns At Raia Drogasil (BVMF:RADL3) Appear To Be Weighed Down
Apr 10The Raia Drogasil S.A. (BVMF:RADL3) Yearly Results Are Out And Analysts Have Published New Forecasts
Mar 10Is Raia Drogasil (BVMF:RADL3) A Risky Investment?
Feb 27Returns On Capital At Raia Drogasil (BVMF:RADL3) Have Hit The Brakes
Jan 07Here's Why Raia Drogasil (BVMF:RADL3) Has Caught The Eye Of Investors
Dec 07Raia Drogasil (BVMF:RADL3) Seems To Use Debt Quite Sensibly
Nov 22Raia Drogasil (BVMF:RADL3) Could Be Struggling To Allocate Capital
Sep 08Here's Why Raia Drogasil (BVMF:RADL3) Has Caught The Eye Of Investors
Aug 24Is Raia Drogasil (BVMF:RADL3) A Risky Investment?
Aug 09There Are Reasons To Feel Uneasy About Raia Drogasil's (BVMF:RADL3) Returns On Capital
Jun 09With EPS Growth And More, Raia Drogasil (BVMF:RADL3) Is Interesting
May 25Does Raia Drogasil (BVMF:RADL3) Have A Healthy Balance Sheet?
May 10Should You Be Adding Raia Drogasil (BVMF:RADL3) To Your Watchlist Today?
Feb 24These 4 Measures Indicate That Raia Drogasil (BVMF:RADL3) Is Using Debt Reasonably Well
Feb 09Some Investors May Be Worried About Raia Drogasil's (BVMF:RADL3) Returns On Capital
Dec 07Should You Be Adding Raia Drogasil (BVMF:RADL3) To Your Watchlist Today?
Nov 19These 4 Measures Indicate That Raia Drogasil (BVMF:RADL3) Is Using Debt Reasonably Well
Nov 04Returns On Capital At Raia Drogasil (BVMF:RADL3) Paint A Concerning Picture
Sep 01Do Raia Drogasil's (BVMF:RADL3) Earnings Warrant Your Attention?
Aug 17These 4 Measures Indicate That Raia Drogasil (BVMF:RADL3) Is Using Debt Reasonably Well
Jul 28Raia Drogasil (BVMF:RADL3) Will Will Want To Turn Around Its Return Trends
May 10We Think Raia Drogasil (BVMF:RADL3) Can Stay On Top Of Its Debt
Mar 10Do Institutions Own Raia Drogasil S.A. (BVMF:RADL3) Shares?
Feb 16
Is Raia Drogasil S.A.'s (BVMF:RADL3) Recent Performance Tethered To Its Attractive Financial Prospects?
Jan 29You Have To Love Raia Drogasil S.A.'s (BVMF:RADL3) Dividend
Jan 11Did Business Growth Power Raia Drogasil's (BVMF:RADL3) Share Price Gain of 253%?
Dec 24Is Raia Drogasil (BVMF:RADL3) A Risky Investment?
Dec 03Raia Drogasil (BVMF:RADL3) Has A Pretty Healthy Balance Sheet
Aug 25Should We Be Excited About The Trends Of Returns At Raia Drogasil (BVMF:RADL3)?
Aug 12What Kind Of Shareholders Hold The Majority In Raia Drogasil S.A.'s (BVMF:RADL3) Shares?
Aug 12What You Can Learn From Raia Drogasil S.A.'s (BVMF:RADL3) P/E
Jul 30Raia Drogasil (BVMF:RADL3) Is Growing Earnings But Are They A Good Guide?
Jul 17Is Raia Drogasil S.A.'s(BVMF:RADL3) Recent Stock Performance Tethered To Its Strong Fundamentals?
Jul 04Gewinn- und Umsatzwachstumsprognosen
| Datum | Umsatz | Gewinne | Freier Cashflow | Bargeld aus operativen Tätigkeiten | Durchschn. Anz. Analysten |
|---|---|---|---|---|---|
| 12/31/2026 | 50,529 | 1,896 | 1,190 | 2,856 | 9 |
| 12/31/2025 | 44,679 | 1,458 | 918 | 2,414 | 11 |
| 12/31/2024 | 39,060 | 1,141 | 535 | 2,774 | 5 |
| 9/30/2024 | 37,701 | 1,110 | 1,109 | 2,360 | N/A |
| 6/30/2024 | 36,388 | 1,039 | 441 | 1,671 | N/A |
| 3/31/2024 | 35,143 | 1,051 | 765 | 2,040 | N/A |
| 12/31/2023 | 33,974 | 1,055 | 481 | 1,785 | N/A |
| 9/30/2023 | 32,886 | 1,079 | 714 | 2,034 | N/A |
| 6/30/2023 | 31,700 | 1,031 | 883 | 2,186 | N/A |
| 3/31/2023 | 30,436 | 1,048 | 1,007 | 2,248 | N/A |
| 12/31/2022 | 29,067 | 996 | 493 | 1,682 | N/A |
| 9/30/2022 | 27,705 | 881 | 563 | 1,590 | N/A |
| 6/30/2022 | 26,380 | 820 | 871 | 1,805 | N/A |
| 3/31/2022 | 25,069 | 718 | 322 | 1,232 | N/A |
| 12/31/2021 | 24,127 | 752 | 701 | 1,557 | N/A |
| 9/30/2021 | 23,207 | 743 | 772 | 1,577 | N/A |
| 6/30/2021 | 22,136 | 743 | 984 | 1,737 | N/A |
| 3/31/2021 | 20,737 | 535 | 716 | 1,349 | N/A |
| 12/31/2020 | 20,067 | 484 | 801 | 1,477 | N/A |
| 9/30/2020 | 19,298 | 409 | 620 | 901 | N/A |
| 6/30/2020 | 18,806 | 713 | 73 | 311 | N/A |
| 3/31/2020 | 18,562 | 807 | 680 | 969 | N/A |
| 12/31/2019 | 17,566 | 772 | 462 | 749 | N/A |
| 9/30/2019 | 16,778 | 803 | 103 | 805 | N/A |
| 6/30/2019 | 15,933 | 472 | 236 | 985 | N/A |
| 3/31/2019 | 15,321 | 470 | -46 | 708 | N/A |
| 12/31/2018 | 14,801 | 502 | -20 | 683 | N/A |
| 9/30/2018 | 14,306 | 519 | -72 | 570 | N/A |
| 6/30/2018 | 13,966 | 527 | N/A | 674 | N/A |
| 3/31/2018 | 13,589 | 528 | N/A | 691 | N/A |
| 12/31/2017 | 13,213 | 511 | N/A | 629 | N/A |
| 9/30/2017 | 12,768 | 464 | N/A | 601 | N/A |
| 6/30/2017 | 12,252 | 444 | N/A | 603 | N/A |
| 3/31/2017 | 11,798 | 462 | N/A | 597 | N/A |
| 12/31/2016 | 11,257 | 448 | N/A | 556 | N/A |
| 9/30/2016 | 10,658 | 438 | N/A | 528 | N/A |
| 6/30/2016 | 10,042 | 407 | N/A | 390 | N/A |
| 3/31/2016 | 9,446 | 360 | N/A | 410 | N/A |
| 12/31/2015 | 8,898 | 340 | N/A | 502 | N/A |
| 9/30/2015 | 8,448 | 325 | N/A | 505 | N/A |
| 6/30/2015 | 8,074 | 309 | N/A | 432 | N/A |
| 3/31/2015 | 7,668 | 263 | N/A | 437 | N/A |
| 12/31/2014 | 7,351 | 221 | N/A | 340 | N/A |
| 9/30/2014 | 7,023 | 187 | N/A | 315 | N/A |
| 6/30/2014 | 6,738 | 138 | N/A | 341 | N/A |
| 3/31/2014 | 6,495 | 116 | N/A | 240 | N/A |
| 12/31/2013 | 6,207 | 101 | N/A | 295 | N/A |
Analystenprognosen zum zukünftigen Wachstum
Einkommen vs. Sparrate: RADL3Das prognostizierte Gewinnwachstum (24.8% pro Jahr) liegt über der Sparquote (10.4%).
Ertrag vs. Markt: RADL3Die Erträge des Unternehmens (24.8% pro Jahr) werden voraussichtlich schneller wachsen als der Markt BR (12.8% pro Jahr).
Hohe Wachstumserträge: RADL3Es wird erwartet, dass die Erträge des Unternehmens in den nächsten 3 Jahren erheblich steigen werden.
Einnahmen vs. Markt: RADL3Die Einnahmen des Unternehmens (12% pro Jahr) werden voraussichtlich schneller wachsen als der Markt BR (7.3% pro Jahr).
Hohe Wachstumseinnahmen: RADL3Die Einnahmen des Unternehmens (12% pro Jahr) werden voraussichtlich langsamer wachsen als 20% pro Jahr.
Wachstumsprognosen für den Gewinn je Aktie
Künftige Eigenkapitalrendite
Künftige Eigenkapitalrendite: RADL3Die Eigenkapitalrendite des Unternehmens wird in 3 Jahren voraussichtlich hoch sein (21.9%)